Loratadine D Tablet, Film Coated, Extended Release
Product Images NDC 45802-122

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Loratadine D (NDC 45802-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

This is a description of a medication with the NDC code 45802-122-60. The medication is called Loratadine-D X and comes in the form of extended-release tablets containing a combination of Pseudoephedrine Sulfate (120 mg) and Loratadine (5 mg). It is used as a nasal decongestant and antihistamine to help relieve nasal and sinus congestion, sneezing, runny nose, itchy, watery eyes, and itchy throat or nose due to allergies. It is designed to work for 12 hours and is comparable to Claritin-D. The medication is suitable for indoor and outdoor allergies and comes in a packaging of 20 tablets per box.*

FDA Label Image

Image 02

This is a drug information sheet providing details on the active ingredients, uses, warnings, directions, and other relevant information about a medication. The medication can provide temporary relief from allergy and cold symptoms. The document mentions several warnings, including the risk of drug interactions with MAOIs, high blood pressure, and thyroid disease. It also outlines dosage instructions and lists the inactive ingredients found in the medication. The medication should be kept out of reach of children and exclusively used according to the instructions mentioned. The drug is distributed by Perrigo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.